Europe Pharmaceuticals Market Research Reports - Data on Pharmaceuticals in Europe page 1

Printer Format

Region:	All Regions > Europe
Category:	All Categories > Life Sciences > Pharmaceuticals

(2136 reports matching your criteria)

Lithuania Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... with the market expected to increase by a local currency margin of 2.5%year-on-year (y-o-y) to reach LTL1.68bn (US$618mn) in 2012 at consumer prices. However, in US dollarterms, the market's value will shrink by 6.3%, indicating ... \| more...	$1,175.00
Romania Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... are a small improvement, though definitely not what producerswould have wanted ideally. With part of the objective of the claw-back tax to improve the timeliness ofpayments for reimbursed medicines, which has been a major difficulty ... \| more...	$1,175.00
Portugal Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... Portugal has already made considerable savings in the healthcaresectors, with changes such as the introduction of e-prescriptions and prescribing by active ingredients,changes to reference pricing, reductions in pharmacy margins and price cuts just some of ... \| more...	$1,175.00
Hungary Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... margins and introduced insecurityto an already difficult economic environment, and we continue to expect a contraction in the size of theHungarian pharmaceutical market in 2012 and 2013. Consequently, Hungarian drugmakers will have tobecome even more ... \| more...	$1,175.00
Serbia Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... consumption is also expected to rise. However, financial inefficiencies within the healthinsurance system mean that the National Health Insurance Institution (RZZO) is unable to always meet itsobligations on time, leaving patients to pay for formerly ... \| more...	$1,175.00
Slovakia Pharmaceuticals and Healthcare Report Q1 2013 1/16/2013 \| published by: Business Monitor International ... this is realised. We do not expect either of the two private insurers - Dôvera or DutchownedUnion - will surrender their businesses without a fight, with Union in particular well-placedto oppose the move, potentially invoking ... \| more...	$1,175.00
Switzerland Pharmaceuticals and Healthcare Report Q1 2013 1/9/2013 \| published by: Business Monitor International ... believes the government needs to do more to alter patients' attitudestowards these drugs as this is the main growth deterrent. Headline Expenditure Projections Pharmaceuticals: CHF6.77bn (US$7.63bn) in 2011 to CHF6.58bn (US$7.00bn) in 2012; -2.8% declinein ... \| more...	$1,175.00
Incontinence in Slovenia 1/8/2013 \| published by: Euromonitor International ... embarrassing condition. As is the case in much of Europe, Slovenia is a rapidly ageing society. According to the 2011 report “Ageing in Slovenia”, produced by the Statistical Office of Slovenia, from 1989 to 2009 ... \| more... Search inside this report	$900.00
Poland Pharmaceuticals and Healthcare Report Q1 2013 1/2/2013 \| published by: Business Monitor International ... has shifted towards the Polishconsumer, as the harsher reimbursement regime has caused private contributions to prescriptionpayments rise. We forecast a return to growth in 2013, driven by private consumption as the Polishgovernment entrenches cuts to ... \| more...	$1,175.00
Ukraine Pharmaceuticals and Healthcare Report Q1 2013 1/2/2013 \| published by: Business Monitor International ... represent a very large business risk for internationaldrugmakers operating in the country. While Ukraine remains one of Central and Eastern Europe (CEE)'smore promising pharmaceutical markets given its favourable demographics and disease profile, itschronic lack of ... \| more...	$1,175.00
Global Markets for Diabetes Therapeutics and Diagnostics - Focus on Europe 1/1/2013 \| published by: BCC Research ... Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017 Identification of markets based on epidemiological data and projections, plus information on R&D ... \| more...	$3,900.00
OTC Medications – UK – a snapshot (2012) 12/28/2012 \| published by: Mintel - Snapshots ... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in UK is given in GBP with a minimum ... \| more... Search inside this report	$600.00
Vitamins & Minerals – UK – a snapshot (2012) 12/28/2012 \| published by: Mintel - Snapshots ... prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in UK is given in GBP with a minimum of five years' ... \| more... Search inside this report	$600.00
Croatia Pharmaceuticals and Healthcare Report Q1 2013 12/26/2012 \| published by: Business Monitor International ... from the EU. The implementation of a clawbacktax at the start of the year will increase pricing pressures. VAT rises and inflation suggest growth seen in2012 will not be due to increased drug consumption. We ... \| more...	$1,175.00
Belgium Pharmaceuticals and Healthcare Report Q1 2013 12/26/2012 \| published by: Business Monitor International ... local currency and US dollar terms, largely on account of cost containmentmeasures and patent expirations. Nevertheless, foreign companies are expected to continue using Belgianproduction sites for exports, the country also being a popular re-export source. ... \| more...	$1,175.00
Bulgaria Pharmaceuticals and Healthcare Report Q1 2013 12/26/2012 \| published by: Business Monitor International ... expected to be used to purchase newequipment, upgrade hospitals and generally improve Bulgarian health services. We have long highlightedthe likelihood of increased public spending ahead of the 2013 parliamentary election, although we do notforesee significant ... \| more...	$1,175.00
France Pharmaceuticals and Healthcare Report Q1 2013 12/26/2012 \| published by: Business Monitor International ... EUR35.01bn (US$48.66bn) in 2011 to EUR34.17bn (US$43.39bn) in 2012;-2.4% in local currency terms and -10.8% in US dollar terms. Local currency forecast broadlyunchanged from Q312. Healthcare: EUR234.30bn (US$325.68bn) in 2011 to EUR239.29bn (US$303.89bn) in 2012;+2.1% ... \| more...	$1,175.00
Italy Pharmaceuticals and Healthcare Report Q1 2013 12/26/2012 \| published by: Business Monitor International ... theyear. BMI notes that this does not bode well for drugmakers selling their products in Italy as the successof the implemented policies may encourage the enforcement of further cost-containment measures,which, together with the ongoing public ... \| more...	$1,175.00
OTC Medications – Netherlands – a snapshot (2012) 12/19/2012 \| published by: Mintel - Snapshots ... excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Netherlands is given in EUR with a minimum ... \| more... Search inside this report	$600.00
Pharmaceuticals in France: ISIC 2423 12/18/2012 \| published by: Euromonitor International ... the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new ... \| more... Search inside this report	$600.00
Healthcare, Regulatory and Reimbursement Landscape - Denmark 12/12/2012 \| published by: GlobalData ... on Denmark`s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights ... \| more... Search inside this report	$1,995.00
Belgium Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others 12/12/2012 \| published by: GlobalData ... Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others” provides key market data on the Belgium Anesthesia and Respiratory Devices market. The report ... \| more... Search inside this report	$2,500.00
Vitamins & Minerals – Spain – a snapshot (2012) 12/12/2012 \| published by: Mintel - Snapshots ... prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in Spain is given in EUR with a minimum of five years' ... \| more... Search inside this report	$600.00
Vitamins & Minerals – France – a snapshot (2012) 12/12/2012 \| published by: Mintel - Snapshots ... prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in France is given in EUR with a minimum of five years' ... \| more... Search inside this report	$600.00
Getting Social With Disease: How Public Health Authorities in Central and Eastern Europe can Improve Outbreak Predictions with Social Media 12/11/2012 \| published by: IDC ... whether something "small" like an off-the-shelf analytics application or "large" like a full-scale migration of systems and software to a cloud-based delivery model. Usually this is okay. But in the realm of public health, it ... \| more... Search inside this report	$1,500.00

< prev 1 2 3 4 5 6 7 8 9 10 next >

Matching Categories

Matching geography

Research assistance

Join Alert Me now!